Teladoc Eyes Buying Back 'A Substantial Portion' Of $1 Billion Convertible Notes, Possibly Before Year-End
The new CFO laid out a two-phase plan, subject to market conditions, for the June 2027 maturity of the $1 billion in notes.
Teladoc Health, the virtual care company, intends to deal with its $1 billion in convertible notes due in June 2027 in two phases, Chief Financial Officer Mike Rasher said on the company's third-quarter earnings call Wednesday. Phase one could be a buyback of a substantial portion, potentially before year-end.
Two phases, subject to the market
Rasher said the first step would potentially use available cash plus proceeds from more traditional debt financing, subject to market conditions. The remaining balance would be repaid with cash at maturity in June 2027.
After that maturity, he said, the company expects a meaningfully lower gross debt position. He also cautioned that the cash flow and net loss per share guidance ranges do not include any potential effect from changes to the current debt structure.
Rasher joined in late August, and CEO Chuck Divita introduced him as bringing over 12 years of CFO experience. Analysts did not ask about the refinancing; their questions centered on BetterHelp and Teladoc One.
Cash pile and leverage
Teladoc ended the quarter with $850 million in cash and equivalents, up $76 million from the prior quarter. Net debt to trailing adjusted EBITDA fell to 0.5 times, from one time a year earlier.
Free cash flow was $76 million in the quarter and $85 million for the first nine months. Guidance for the year was narrowed to $135 million to $165 million, with the midpoint unchanged.
The company provides virtual care by video, phone, app and text, through an Integrated Care segment sold to employers and health plans and a BetterHelp online therapy segment.
Quarter behind the balance sheet
Consolidated revenue was $605 million, down 3.4% from a year earlier. Adjusted EBITDA of $79 million grew 13.5%, and the adjusted EBITDA margin rose about 200 basis points (two percentage points) to 13.1%. Net loss per share was 15 cents, against 28 cents a year earlier.
For 2026, Rasher now expects revenue of $2.39 billion to $2.44 billion and adjusted EBITDA of $277 million to $303 million. BetterHelp insurance revenue was $32 million, and the company expects $99 million to $105 million for the year.
Whether the first-phase repurchase launches before year-end is the next marker; Rasher said it would only potentially happen then.
Sources
- Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates — Yahoo Finance
- Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates — Yahoo Finance
- Teladoc: Q3 Earnings Snapshot – WTOP News — wtop.com
- Teladoc Health Stock Rises After Q3 Double Beat — benzinga.com
- Is Teladoc Health (TDOC) Reasonable Given Its Future Cash Flow? — Yahoo Finance